Ra Pharmaceuticals Inc

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Stochastic Oscillator



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 34 12.1 0.56% 1.27% 10.5% -4.4% 132.7%
SHORT 33 11.3 0.48% 0.94% 7.7% -9.3% -34.2%


Technical Analysis

In technical analysis of securities trading the stochastic oscillator is a momentum indicator that uses support and resistance levels. Dr George Lane developed this indicator in the late 1950s. The term stochastic refers to the point of a current price in relation to its price range over a period of time. This method attempts to predict price turning points by comparing the closing price of a security to its price range.

Calculation: Stochastic Oscillator:
1) %K = (Current Close - Lowest Low)/(Highest High - Lowest Low) * 100;
2) %D = 3-day SMA of %K Lowest Low = lowest low for the look-back period Highest High = highest high for the look-back period %K is multiplied by 100 to move the decimal point two places;

PROFILE: Ra Pharmaceuticals Inc (RARX)

Stock Exchange: NASDAQ
Company: Ra Pharmaceuticals Inc
Ticker Codes: | RARX | NASDAQ:RARX |

About Ra Pharmaceuticals Inc (NASDAQ:RARX):

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); and is in Phase II clinical trial for treating patients with generalized myasthenia gravis (gMG), as well as in Phase 1b clinical trial for treating atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN). The company's preclinical testing products include Factor D inhibition for orphan renal and dense deposit diseases, and C3 glomerulonephritis; Oral C5 inhibitor for PNH, gMG, aHUS, LN, and central nervous system (CNS) diseases; and other complement inhibitors for autoimmune/CNS diseases. It has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Top 10:

Stochastic Oscillator

Company Close Change(%) Volume Value Signal
ATRC Atricure Inc 38.25 4.1 790,500 78.4 BEARISH CROSSUNDER
PETS Petmed Express Inc 27.26 2.8 905,900 59.3 BEARISH CROSSUNDER
AMD Adv Micro Devices 50.93 2.3 57,722,500 51.4 BEARISH CROSSUNDER
MTSC MTS Systems 51.67 2.2 113,400 77.8 BEARISH CROSSUNDER
MAT Mattel Inc 14.28 1.9 3,800,300 76.3 BEARISH CROSSUNDER
TRUP Trupanion Inc 32.79 1.8 227,300 68.3 BEARISH CROSSUNDER
XLNX Xilinx Inc 102.89 1.5 3,974,000 78.6 BEARISH CROSSUNDER
EA Electronic Arts Inc 112.93 1.5 3,053,200 74.1 BEARISH CROSSUNDER
ERI Eldorado Resorts 61.34 1.3 2,145,200 78.4 BEARISH CROSSUNDER
NMIH Nmi Holdings 33.53 1.1 468,400 68.9 BEARISH CROSSUNDER